Kristine Bernard

607 total citations
24 papers, 462 citations indexed

About

Kristine Bernard is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kristine Bernard has authored 24 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kristine Bernard's work include Iron Metabolism and Disorders (13 papers), Erythropoietin and Anemia Treatment (8 papers) and Hemoglobinopathies and Related Disorders (8 papers). Kristine Bernard is often cited by papers focused on Iron Metabolism and Disorders (13 papers), Erythropoietin and Anemia Treatment (8 papers) and Hemoglobinopathies and Related Disorders (8 papers). Kristine Bernard collaborates with scholars based in United States, Australia and Canada. Kristine Bernard's co-authors include William Strauss, Lee F. Allen, Zhu Li, Iain C. Macdougall, Julie Krop, Robert Kaper, David J. Hetzel, N. Franklin Adkinson, Sarah Acaster and Glenn M. Chertow and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Kristine Bernard

23 papers receiving 443 citations

Peers

Countries citing papers authored by Kristine Bernard

Since Specialization

Citations

This map shows the geographic impact of Kristine Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine Bernard more than expected).

Fields of papers citing papers by Kristine Bernard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine Bernard. The network helps show where Kristine Bernard may publish in the future.

Co-authorship network of co-authors of Kristine Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine Bernard. A scholar is included among the top collaborators of Kristine Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine Bernard. Kristine Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults 2025 ·Annals of Allergy Asthma & Immunology ·William R. Lumry, Michele Gunsior, Theodora Cohen, Kristine Bernard, (unknown), (unknown), Christopher Morabito	2
2	Initial Results from a Phase 1 Single Ascending Dose Clinical Trial of STAR-0215, an Investigational Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for Hereditary Angioedema (HAE), in Healthy Subjects Followed for at Least 3 Months 2023 ·Journal of Allergy and Clinical Immunology ·Christopher Morabito, Christian V. Stevens, (unknown), (unknown), Pradeep Bista, Kristine Bernard, (unknown), Michele Gunsior, Andrew Nichols	3
3	SUPPORT FOR STAR-0215 ADMINISTERED EVERY THREE- OR SIX-MONTHS FOR HEREDITARY ANGIOEDEMA: PHASE 1A Results: 2023 ·Annals of Allergy Asthma & Immunology ·(unknown), Ted Cohen, Michele Gunsior, Andrew Nichols, (unknown), Kristine Bernard, Per Gustafson, William R. Lumry	1
4	Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial 2018 ·American Journal of Hematology ·N. Franklin Adkinson, William Strauss, Iain C. Macdougall, Kristine Bernard, Michael Auerbach, Robert Kaper, Glenn M. Chertow, Julie Krop	97
5	Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions 2017 ·Journal of Blood Medicine ·(unknown), William Strauss, Kristine Bernard, Robert Kaper, Iain C. Macdougall, Julie Krop	9
6	Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer 2017 ·Journal of Blood Medicine ·Saroj Vadhan‐Raj, Naomi V. Dahl, Kristine Bernard, Zhu Li, William Strauss	11
7	The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale 2017 ·BMC Nephrology ·Iain C. Macdougall, Naomi V. Dahl, Kristine Bernard, Zhu Li, (unknown), William Strauss	8
8	Effects of IV iron treatment with ferumoxytol on health-related quality of life of patients with iron deficiency anemia 2016 ·The Journal of Community and Supportive Oncology ·William Strauss, Naomi V. Dahl, Saroj Vadhan‐Raj, Sarah Acaster, Kristine Bernard, Rene Dickerhoof, Zhu Li, Lee F. Allen	6
9	Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders 2016 ·Clinical and Experimental Gastroenterology ·William Strauss, Naomi V. Dahl, (unknown), Charles F. Barish, David J. Hetzel, Kristine Bernard, Zhu Li, Lee F. Allen	15
10	A microfluidic device for efficient chemical testing using Caenorhabditis elegans 2015 ·Biomedical Microdevices ·Pengfei Song, (unknown), (unknown), Kristine Bernard, Siegfried Hekimi, Xinyu Liu	12
11	Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia 2015 ·Health and Quality of Life Outcomes ·Sarah Acaster, Rene Dickerhoof, Kendra DeBusk, Kristine Bernard, William Strauss, Lee F. Allen	69
12	A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy 2014 ·American Journal of Hematology ·David J. Hetzel, William Strauss, Kristine Bernard, Zhu Li, (unknown), Lee F. Allen	63
13	Measuring fatigue in iron deficiency anemia patients: A psychometric validation study 2013 ·Value in Health ·Rene Dickerhoof, Kendra DeBusk, Kristine Bernard, William Strauss, Lee F. Allen, Sarah Acaster	1
14	Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron 2013 ·American Journal of Hematology ·Saroj Vadhan‐Raj, William Strauss, (unknown), Kristine Bernard, Ralph V. Boccia, (unknown), Lee F. Allen	63
15	Tu1073 Evaluation of Ferumoxytol Treatment for Iron Deficiency Anemia in Patients With Gastrointestinal Disorders Who Have a History of Unsatisfactory Oral Iron Therapy: Results of a Phase III, Randomized, Placebo-Controlled Trial 2013 ·Gastroenterology ·(unknown), Mitchell I. Cohen, William Strauss, Charles F. Barish, Kristine Bernard, (unknown), Lee F. Allen	4
16	P485 IV iron treatment of iron deficiency anaemia with Ferumoxytol in patients with gastrointestinal disorders unable to take oral iron: a randomized controlled trial versus iron sucrose 2013 ·Journal of Crohn s and Colitis ·David J. Hetzel, William Strauss, Kristine Bernard, (unknown), Lee F. Allen	2
17	P-143 Efficacy and Safety of intravenous Ferumoxytol for the Treatment of Iron Deficiency Anemia in Patients with IBD 2013 ·Inflammatory Bowel Diseases ·David J. Hetzel, Charles F. Barish, Naomi V. Dahl, Kristine Bernard, (unknown), William Strauss	0
18	Potential New Treatment Option for Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy- Results of a Phase III, Randomized, Open-Label, Active-Controlled Trial of Ferumoxytol. 2012 ·Blood ·David J. Hetzel, (unknown), Kristine Bernard, William Strauss, Michael D. Cressman, Zhu Li, Lee F. Allen	2
19	Ferumoxytol Treatment Results in Robust Hemoglobin Increases in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy in a Phase III, Randomized, Placebo-Controlled Trial. 2012 ·Blood ·(unknown), Michael D. Cressman, (unknown), William Strauss, (unknown), Kristine Bernard, Zhu Li, Lee F. Allen	2
20	A Model of Oxidative Stress Management: Moderation of Carbohydrate Metabolizing Enzymes in SOD1-Null Drosophila melanogaster 2011 ·PLoS ONE ·Kristine Bernard, Tony L. Parkes, Thomas Merritt	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact